Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Breast Cancer
Jul 1, 2024, 18:24 |
Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jul 1, 2024, 13:46 |
Blog
The July issue of Annals of Oncology
Annals of Oncology shared a post on LinkedIn: “New online - the July issue of…
Jul 1, 2024, 12:25 |
Blog
Allison Institute announced appointment of two immunobiology experts as associate members
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center announced the appointment…
Jul 1, 2024, 05:46 |
Cancer Types
Endometrioid Adenocarcinoma: What patients should know about
What is Endometrioid Adenocarcinoma? Endometrioid adenocarcinoma is a type of cancer that originates in the…
Jun 30, 2024, 16:30 |
Insight
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn: “Patients with stage…
Jun 30, 2024, 04:51 |
Blog
Faisal Mahmood: Meet HEST-1k, a collection of 1,108 ST samples
Faisal Mahmood, Associate Professor at Harvard University, shared on X: "What would you do with 1000+…
Jun 29, 2024, 14:09 |
Insight
Fumiko Ladd Chino: Did you know that the prior authorisation reform bill was reintroduced into Congress
Fumiko Ladd Chino shared a post on X: “Did you know that the prior authorisation reform…
Jun 29, 2024, 04:58 |
Societies
Maryam Lustberg: Thank you to all the advocacy leaders who presented in the MASCC session
Maryam Lustberg shared on LinkedIn: "Thank you to all the advocacy leaders from around the…
Jun 29, 2024, 03:18 |
Blog
Peter Schmid's findings on atezolizumab and sacituzumab govitecan for advanced TNBC - ESMO
ESMO shared a post on LinkedIn: “For ESMO members: Breaking Science in Breast Cancer. Peter Schmid…
136
137
138
139
140
All:
2160
Posts:
1371 - 1380
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube